People · Operator
Named in public records as an officer, director or promoter · active 2010–2015 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| ProPhase Labs, Inc. | — | Biotechnology | Seed | $8.4M | $8.1M | 2010 |
Louis V. Gleckel at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Louis V. Gleckel on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Carolina Abenante | 1 | 2 |
| John V. DeShazo | 1 | 1 |
| Mark V. Leventhal | 1 | 1 |
| James V. McCubbin | 1 | 1 |
| Mark V. Frank | 1 | 1 |
| Mark V. Burnett | 1 | 1 |
| Robert V. Cuddihy, Jr. | 1 | 1 |
| Ted Karkus | 1 | 1 |
| Jason V. Barr | 1 | 1 |
| LOUIS GECKEL | 1 | 1 |
| WARREN HIRSCH | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.